Long-Term Safety and Efficacy Study of Peginterferon Beta-1a
NCT01332019
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1077
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing Multiple Sclerosis
Interventions
DRUG:
peginterferon beta-1a
Sponsor
Biogen